Clinical significance of pulmonary hypertension in interstitial lung disease: A consensus statement from the Pulmonary Vascular Research Institute’s innovative drug development initiative-Group 3 pulmonary hypertension

By sjmartinez • July 1, 2022

Nikkho SM, Richter MJ, Shen E, Abman SH, Antoniou K, Chung J, Fernandes P, Hassoun P, Lazarus HM, Olschewski H, Piccari L, Psotka M, Saggar R, Shlobin OA, Stockbridge N, Vitulo P, Vizza CD, Wort SJ, Nathan SD. Clinical significance of pulmonary hypertension in interstitial lung disease: A consensus statement from the Pulmonary Vascular Research Institute's innovative drug development initiative-Group 3 pulmonary hypertension. Pulm Circ. 2022 Jul 1;12(3):e12127. doi: 10.1002/pul2.12127. PMID: 36016668; PMCID: PMC9395696.

Tags: Epidemiology, interstitial lung disease, prognosis, Publications, pulmonary hypertension, Pulmonary, Critical Care & Sleep Medicine, symptom assessment and management

A case report of verapamil toxicity leading to haemodynamic compromise in obstructive hypertrophic cardiomyopathy

Gau JW, Rader F, Mody B, Lee AY. A case report of verapamil toxicity leading to haemodynamic compromise in obstructive hypertrophic cardiomyopathy. Eur Heart J[...]

JPEN Journal Club 89. Signal-finding studies

Koretz RL. JPEN Journal Club 89. Signal-finding studies. JPEN J Parenter Enteral Nutr. 2024 Dec 10. doi: 10.1002/jpen.2709. Epub ahead of print. PMID: 39659167.

Duration of sodium zirconium cyclosilicate treatment and continuation of RAASi therapy after a hyperkalaemia episode

Pollack CV Jr, Arroyo D, Kanda E, Lázaro IJS, Lesén E, Franzén S, Gray CM, Lipińska A, Murohara T, Rastogi A. Duration of sodium zirconium[...]